GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shenzhen Hepalink Pharmaceutical Group Co Ltd (OTCPK:SHEZF) » Definitions » Cyclically Adjusted PS Ratio

Shenzhen Hepalink Pharmaceutical Group Co (Shenzhen Hepalink Pharmaceutical Group Co) Cyclically Adjusted PS Ratio : 2.40 (As of Jun. 09, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Shenzhen Hepalink Pharmaceutical Group Co Cyclically Adjusted PS Ratio?

As of today (2024-06-09), Shenzhen Hepalink Pharmaceutical Group Co's current share price is $0.7206. Shenzhen Hepalink Pharmaceutical Group Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was $0.30. Shenzhen Hepalink Pharmaceutical Group Co's Cyclically Adjusted PS Ratio for today is 2.40.

The historical rank and industry rank for Shenzhen Hepalink Pharmaceutical Group Co's Cyclically Adjusted PS Ratio or its related term are showing as below:

SHEZF' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 2.28   Med: 6.35   Max: 10.92
Current: 2.83

During the past years, Shenzhen Hepalink Pharmaceutical Group Co's highest Cyclically Adjusted PS Ratio was 10.92. The lowest was 2.28. And the median was 6.35.

SHEZF's Cyclically Adjusted PS Ratio is ranked worse than
62.58% of 743 companies
in the Drug Manufacturers industry
Industry Median: 2.05 vs SHEZF: 2.83

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Shenzhen Hepalink Pharmaceutical Group Co's adjusted revenue per share data for the three months ended in Mar. 2024 was $0.130. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is $0.30 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Shenzhen Hepalink Pharmaceutical Group Co Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Shenzhen Hepalink Pharmaceutical Group Co's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shenzhen Hepalink Pharmaceutical Group Co Cyclically Adjusted PS Ratio Chart

Shenzhen Hepalink Pharmaceutical Group Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.18 6.84 6.22 4.12 3.51

Shenzhen Hepalink Pharmaceutical Group Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.35 3.58 3.74 3.51 2.44

Competitive Comparison of Shenzhen Hepalink Pharmaceutical Group Co's Cyclically Adjusted PS Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Shenzhen Hepalink Pharmaceutical Group Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shenzhen Hepalink Pharmaceutical Group Co's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shenzhen Hepalink Pharmaceutical Group Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Shenzhen Hepalink Pharmaceutical Group Co's Cyclically Adjusted PS Ratio falls into.



Shenzhen Hepalink Pharmaceutical Group Co Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Shenzhen Hepalink Pharmaceutical Group Co's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=0.7206/0.3
=2.40

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shenzhen Hepalink Pharmaceutical Group Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Shenzhen Hepalink Pharmaceutical Group Co's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.13/115.2271*115.2271
=0.130

Current CPI (Mar. 2024) = 115.2271.

Shenzhen Hepalink Pharmaceutical Group Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 0.077 98.200 0.090
201409 0.065 98.900 0.076
201412 0.066 99.000 0.077
201503 0.092 99.900 0.106
201506 0.056 99.500 0.065
201509 0.055 100.500 0.063
201512 0.082 100.600 0.094
201603 0.083 102.200 0.094
201606 0.064 101.400 0.073
201609 0.048 102.400 0.054
201612 0.073 102.600 0.082
201703 0.053 103.200 0.059
201706 0.071 103.100 0.079
201709 0.088 104.100 0.097
201712 0.118 104.500 0.130
201803 0.122 105.300 0.134
201806 0.153 104.900 0.168
201809 0.131 106.600 0.142
201812 0.173 106.500 0.187
201903 0.122 107.700 0.131
201906 0.129 107.700 0.138
201909 0.114 109.800 0.120
201912 0.170 111.200 0.176
202003 0.160 112.300 0.164
202006 0.142 110.400 0.148
202009 0.093 111.700 0.096
202012 0.179 111.500 0.185
202103 0.133 112.662 0.136
202106 0.196 111.769 0.202
202109 0.160 112.215 0.164
202112 0.186 113.108 0.189
202203 0.205 114.335 0.207
202206 0.188 114.558 0.189
202209 0.159 115.339 0.159
202212 0.172 115.116 0.172
202303 0.129 115.116 0.129
202306 0.135 114.558 0.136
202309 0.126 115.339 0.126
202312 0.132 114.781 0.133
202403 0.130 115.227 0.130

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Shenzhen Hepalink Pharmaceutical Group Co  (OTCPK:SHEZF) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Shenzhen Hepalink Pharmaceutical Group Co Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Shenzhen Hepalink Pharmaceutical Group Co's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Shenzhen Hepalink Pharmaceutical Group Co (Shenzhen Hepalink Pharmaceutical Group Co) Business Description

Traded in Other Exchanges
Address
No. 21 Langshan Road, Songping Mountain, Guangdong Province, Nanshan District, Shenzhen, CHN, 518057
Shenzhen Hepalink Pharmaceutical Group Co Ltd is a China-based company engaged in biopharmaceutical production, biopharmaceutical services, biopharmaceutical trading and biopharmaceutical research and development. The company distributes its products both in the domestic and overseas markets. The Group mainly operates three main business segments, including Finished dose pharmaceutical products business; Active pharmaceutical ingredients; CDMO business and Others. Geographical presence of company is in Hong Kong, United States of America, Europe, Mainland China and Other countries. Majority of the company's revenue comes from USA and Europe.

Shenzhen Hepalink Pharmaceutical Group Co (Shenzhen Hepalink Pharmaceutical Group Co) Headlines